Eastern Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
27,740
-4,760
-15% -$273K 0.02% 175
2026
Q1
$1.97M Sell
32,500
-2,768
-8% -$161K 0.03% 169
2025
Q4
$1.9M Buy
35,268
+3,029
+9% +$146K 0.03% 158
2025
Q3
$1.45M Sell
32,239
-140
-0.4% -$6.54K 0.03% 168
2025
Q2
$1.5M Sell
32,379
-3,031
-9% -$149K 0.03% 161
2025
Q1
$2.16M Sell
35,410
-3,309
-9% -$193K 0.04% 147
2024
Q4
$2.19M Sell
38,719
-6,571
-15% -$367K 0.04% 162
2024
Q3
$2.34M Buy
45,290
+39,735
+715% +$1.86M 0.04% 166
2024
Q2
$231K Sell
5,555
-400
-7% -$17.9K 0.01% 182
2024
Q1
$323K Hold
5,955
0.01% 179
2023
Q4
$306K Sell
5,955
-519
-8% -$27.2K 0.01% 183
2023
Q3
$376K Hold
6,474
0.02% 167
2023
Q2
$414K Sell
6,474
-103
-2% -$6.91K 0.02% 165
2023
Q1
$456K Sell
6,577
-1,133
-15% -$79.9K 0.02% 153
2022
Q4
$555K Hold
7,710
0.03% 144
2022
Q3
$548K Sell
7,710
-385
-5% -$27.9K 0.03% 139
2022
Q2
$624K Sell
8,095
-950
-11% -$72.4K 0.03% 146
2022
Q1
$661K Sell
9,045
-10,183
-53% -$684K 0.03% 145
2021
Q4
$1.2M Buy
19,228
+13,212
+220% +$775K 0.05% 127
2021
Q3
$356K Sell
6,016
-33
-0.5% -$2.17K 0.02% 165
2021
Q2
$405K Hold
6,049
0.02% 159
2021
Q1
$382K Sell
6,049
-1,522
-20% -$94.7K 0.02% 154
2020
Q4
$469K Sell
7,571
-1,287
-15% -$79.1K 0.03% 139
2020
Q3
$534K Buy
8,858
+125
+1% +$7.52K 0.03% 129
2020
Q2
$513K Sell
8,733
-726
-8% -$43.4K 0.03% 134
2020
Q1
$526K Sell
9,459
-250
-3% -$15.3K 0.04% 131
2019
Q4
$623K Buy
9,709
+1,873
+24% +$107K 0.04% 121
2019
Q3
$398K Sell
7,836
-1,000
-11% -$47K 0.02% 146
2019
Q2
$400K Sell
8,836
-2,636
-23% -$123K 0.03% 146
2019
Q1
$548K Sell
11,472
-4,025
-26% -$200K 0.04% 137
2018
Q4
$806K Sell
15,497
-1,430
-8% -$76.8K 0.06% 117
2018
Q3
$1.05M Sell
16,927
-4,392
-21% -$261K 0.07% 115
2018
Q2
$1.18M Sell
21,319
-9,160
-30% -$495K 0.08% 116
2018
Q1
$1.93M Sell
30,479
-230,487
-88% -$14.8M 0.13% 110
2017
Q4
$16M Buy
260,966
+445
+0.2% +$27.8K 1.07% 36
2017
Q3
$16.6M Sell
260,521
-3,516
-1% -$205K 1.18% 28
2017
Q2
$14.7M Buy
264,037
+7,266
+3% +$395K 1.08% 36
2017
Q1
$14M Buy
256,771
+195
+0.1% +$10.7K 1.05% 38
2016
Q4
$15M Buy
256,576
+60,052
+31% +$3.28M 1.17% 32
2016
Q3
$10.6M Buy
196,524
+175,781
+847% +$11.3M 0.85% 52
2016
Q2
$1.52M Buy
20,743
+100
+0.5% +$7.07K 0.12% 106
2016
Q1
$1.32M Buy
20,643
+40
+0.2% +$2.52K 0.11% 108
2015
Q4
$1.42M Sell
20,603
-651
-3% -$43K 0.12% 106
2015
Q3
$1.26M Hold
21,254
0.11% 106
2015
Q2
$1.42M Sell
21,254
-605
-3% -$39.9K 0.11% 103
2015
Q1
$1.41M Sell
21,859
-286
-1% -$17.9K 0.11% 107
2014
Q4
$1.31M Sell
22,145
-1,070
-5% -$60.3K 0.1% 103
2014
Q3
$1.19M Sell
23,215
-679
-3% -$33.9K 0.1% 109
2014
Q2
$1.16M Sell
23,894
-789
-3% -$38.9K 0.09% 108
2014
Q1
$1.28M Sell
24,683
-9,244
-27% -$492K 0.11% 101
2013
Q4
$1.8M Sell
33,927
-1,688
-5% -$86K 0.15% 90
2013
Q3
$1.65M Sell
35,615
-6,491
-15% -$285K 0.15% 91
2013
Q2
$1.88M Buy
+42,106
New +$1.83M 0.18% 84

Other funds holding BMY

Eastern Bank's BMY Position: Q2 2026 in Review

Eastern Bank reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2026, selling an estimated $273K and leaving 27,740 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #175.

Eastern Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.6M in Q3 2017. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Eastern Bank held 27,740 shares of Bristol-Myers Squibb worth $1.6M as of Q2 2026.
  • Eastern Bank sold 4,760 Bristol-Myers Squibb shares in Q2 2026, an estimated $273K.
  • Bristol-Myers Squibb made up 0.02% of Eastern Bank's portfolio in Q2 2026, its #175 holding.
  • Eastern Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Eastern Bank's Bristol-Myers Squibb position peaked at $16.6M in Q3 2017.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.